160 related articles for article (PubMed ID: 11408233)
1. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test.
Heine HS; England MJ; Waag DM; Byrne WR
Antimicrob Agents Chemother; 2001 Jul; 45(7):2119-21. PubMed ID: 11408233
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.
Kenny DJ; Russell P; Rogers D; Eley SM; Titball RW
Antimicrob Agents Chemother; 1999 Nov; 43(11):2773-5. PubMed ID: 10543761
[TBL] [Abstract][Full Text] [Related]
4. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
McLaughlin HP; Sue D
BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic sensitivity of the causative agent of glanders].
Kovalev GK; Gnetnev AM
Antibiotiki; 1975 Feb; 20(2):141-4. PubMed ID: 1119794
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.
Judy BM; Whitlock GC; Torres AG; Estes DM
BMC Microbiol; 2009 May; 9():88. PubMed ID: 19426516
[TBL] [Abstract][Full Text] [Related]
7. [Identification of the causative agents of glanders and melioidosis by polymerase chain reaction].
Tkachenko GA; Antonov VA; Zamaraev VS; Iliukhin VI
Mol Gen Mikrobiol Virusol; 2003; (3):18-22. PubMed ID: 12966921
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance in Burkholderia species.
Rhodes KA; Schweizer HP
Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Burkholderia cepacia complex isolates: Comparison of disk diffusion, Etest®, agar dilution, and broth microdilution methods.
Fehlberg LC; Nicoletti AG; Ramos AC; Rodrigues-Costa F; de Matos AP; Girardello R; Marques EA; Gales AC
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):422-427. PubMed ID: 27638346
[TBL] [Abstract][Full Text] [Related]
11. Effects of inoculum size and incubation time on broth microdilution susceptibility testing of lactic acid bacteria.
Egervärn M; Lindmark H; Roos S; Huys G; Lindgren S
Antimicrob Agents Chemother; 2007 Jan; 51(1):394-6. PubMed ID: 17060527
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility patterns of clinical and fish isolates of Laribacter hongkongensis: comparison of the Etest, disc diffusion and broth microdilution methods.
Lau SK; Wong GK; Poon RW; Lee LC; Leung KW; Tse CW; Ho PL; Que TL; Woo PC; Yuen KY
J Antimicrob Chemother; 2009 Apr; 63(4):704-8. PubMed ID: 19202149
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
[TBL] [Abstract][Full Text] [Related]
15. Glanders: off to the races with Burkholderia mallei.
Whitlock GC; Estes DM; Torres AG
FEMS Microbiol Lett; 2007 Dec; 277(2):115-22. PubMed ID: 18031330
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.
Halwani M; Mugabe C; Azghani AO; Lafrenie RM; Kumar A; Omri A
J Antimicrob Chemother; 2007 Oct; 60(4):760-9. PubMed ID: 17673475
[TBL] [Abstract][Full Text] [Related]
17.
Heine HS; Miller L; Halasohoris S; Purcell BK
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674048
[No Abstract] [Full Text] [Related]
18. [Molecular-genetic approaches to diagnosis and intraspecific typing of causative agents of glanders and melioidosis].
Antonov VA; Iliukhin VI
Mol Gen Mikrobiol Virusol; 2005; (2):3-9. PubMed ID: 15954468
[TBL] [Abstract][Full Text] [Related]
19. A novel selective medium for the isolation of Burkholderia mallei from equine specimens.
Kinoshita Y; Cloutier AK; Rozak DA; Khan MSR; Niwa H; Uchida-Fujii E; Katayama Y; Tuanyok A
BMC Vet Res; 2019 May; 15(1):133. PubMed ID: 31064357
[TBL] [Abstract][Full Text] [Related]
20. Detection of the reemerging agent Burkholderia mallei in a recent outbreak of glanders in the United Arab Emirates by a newly developed fliP-based polymerase chain reaction assay.
Scholz HC; Joseph M; Tomaso H; Al Dahouk S; Witte A; Kinne J; Hagen RM; Wernery R; Wernery U; Neubauer H
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):241-7. PubMed ID: 16466896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
